Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Unrelated Donor Registry

An overview of the Welsh Bone Marrow Donor Registry: 10 years of bone marrow donor provision

Abstract

The Welsh Bone Marrow Donor Registry (WBMDR) is in its 11th year of operation and its 4th year as an International ‘Hub’ participating in Bone Marrow Donors Worldwide. It is operated by the Welsh Regional Tissue Typing Laboratory which is accredited by Clinical Pathology Accreditation (UK) Ltd, and the European Federation for Immunogenetics and, together with the Welsh Blood Service, its donor centre, is ISO 9001 Registered. The active donor panel of over 21 000 regular blood donors are all HLA-A, B, DR, DQ typed (over 95% to the split specificity level or higher). All HLA-DR, DQ and over 50% of HLA-A, B typing has been performed by DNA-based methods. CMV antibody status, now tested on all donors, is known on over 70% of subjects. The WBMDR has over 80% success at obtaining Confirmatory Typing samples and operates a rapid Expanded Typing service on stored donor material. It has provided 174 bone marrow donations (140 for UK and 34 for overseas patients), and 11 lymphocyte donations, since its inception in 1989. Bone Marrow Transplantation (2000) 25 , 771–777.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Raffoux C, Marry E, Gebuhrer L . Bone marrow transplantation using voluntary donors. Role of the European Secretariat Nouv Rev Fr Hematol 1991 33: 441–443

    CAS  PubMed  Google Scholar 

  2. Baouz A, Raffoux C . EMDIS European marrow donor information system Comput Meth Prog Biomed 1994 45: 45–46

    Article  CAS  Google Scholar 

  3. Darke C, Guttridge MG, Thompson J et al. HLA class I (A, B) and II (DR, DQ) gene and haplotype frequencies in blood donors from Wales Exp Clin Immunogenet 1998 15: 69–83

    Article  CAS  Google Scholar 

  4. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1998 Tissue Antigens 1999 53: 407–446

    Article  CAS  Google Scholar 

  5. Fussell H, Darke C . HLA-B7QUINN–A new HLA-B7 variant antigen Eur J Immunogenet 1992 19: 449

    Google Scholar 

  6. Fussell H, Thomas M, Street J et al. Serological identification of a new HLA-B7 variant antigen – HLA-B7QUI Eur J Immunogenet 1994 21: 23–31

    Article  CAS  Google Scholar 

  7. Hildebrand WH, Domena JD, Shen SY et al. The HLA-B7Qui antigen is encoded by a subtype of HLA-B27 (B*2708) Tissue Antigens 1994 44: 47–51

    Article  CAS  Google Scholar 

  8. Arnett KL, Adams EJ, Gumperz JE et al. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 (B*0802) Tissue Antigens 1995 46: 316–321

    Article  CAS  Google Scholar 

  9. Darke C, Fussell H, Street J et al. Serological and molecular identification of an HLA-B8 variant – HLA-B8Jon (B*0802) Exp Clin Immunogenet 1997 13: 139–153

    Google Scholar 

  10. Darke C, Street J, Fussell H et al. A new HLA-B44 variant (B44BO (B*4408)) identified by serology Tissue Antigens 1997 50: 32–37

    Article  CAS  Google Scholar 

  11. Guttridge MG, Street J, Thomas M et al. Identification of HLA-A*0224: implications for PCR-SSP HLA typing Tissue Antigens 1999 53: 190–193

    Article  CAS  Google Scholar 

  12. Thompson J, Street J, Guttridge MG et al. HLA-A*2502 – frequency and serology of the product Eur J Immunogenet 1998 25: 77

    Google Scholar 

  13. Guttridge MG, Thompson J, Street J et al. Identification, sequencing and serology of HLA-B*3527 Tissue Antigens 1999 53: 383–385

    Article  CAS  Google Scholar 

  14. Darke C, Guttridge MG, Street J et al. HLA-B*4703: sequence confirmation, serology and distribution Tissue Antigens 1999 53: 586–590

    Article  CAS  Google Scholar 

  15. Darke C, Guttridge MG, Thompson J et al. Molecular, serological and population studies on a novel HLA-B allele – HLA-B*5002 Tissue Antigens 1998 51: 666–670

    Article  CAS  Google Scholar 

  16. Young NT, Darke C . Gene frequency and linkage disequilibrium analysis of HLA-DRB1*04 haplotypes in a South Wales population Eur J Immunogenet 1994 21: 15–22

    Article  CAS  Google Scholar 

  17. Rees T, Guttridge MG, Street J et al. Identification and distribution of HLA-B*15 alleles in a random population Eur J Immunogenet 1997 24: 36

    Google Scholar 

  18. Thompson J, James D, Street J et al. HLA-A2 alleles in Wales: detection, distribution and serology Eur J Immunogenet 1999 26: 47

    Google Scholar 

  19. Thompson J, Guttridge MG, Darke C . Frequency and linkage disequilibrium with HLA-B of the non-serologically defined HLA-Cw alleles Eur J Immunogenet 1996 23: 78

    Google Scholar 

  20. Darke C, Guttridge MG, Thompson J et al. Frequency and linkage disequilibria of HLA-DRB1, DQB1 and DPB1 alleles in blood donors from Wales Eur J Immunogenet 1999 26: 62

    Google Scholar 

  21. Guttridge MG, Darke C . Rare DRB1 and DQB1 haplotypes identified in 2908 random blood donors Eur J Immunogenet 1996 23: 78

    Google Scholar 

  22. Young NT, Street J, Darke C . Immunoglobulin allotype frequencies in responders and nonresponders to the Rh (D) antigen Exp Clin Immunogenet 1995 12: 88–91

    CAS  PubMed  Google Scholar 

  23. Dorak MT, Owen G, Galbraith I et al. Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia Leukemia 1995 9: 875–878

    CAS  PubMed  Google Scholar 

  24. Brown MA, Pile KD, Kennedy LG et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom Ann Rheum Dis 1996 55: 268–270

    Article  CAS  Google Scholar 

  25. Parkes AB, Darke C, Othman S et al. MHC class II and complement polymorphisms in postpartum thyroiditis Eur J Endocrinol 1996 134: 449–453

    Article  CAS  Google Scholar 

  26. Hall FC, Weeks DE, Camilleri JP et al. Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis Quart J Med 1996 89: 821–829

    Article  CAS  Google Scholar 

  27. Brown MA, Kennedy LG, Darke C et al. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis Arth Rheum 1998 41: 460–465

    Article  CAS  Google Scholar 

  28. Long CC, Darke C, Marks R . Celtic ancestry, HLA phenotype and increased risk of skin cancer Br J Dermatol 1998 138: 627–630

    Article  CAS  Google Scholar 

  29. Dorak MT, Lawson T, Machulla HK et al. Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia Blood 1999 94: 694–700

    CAS  PubMed  Google Scholar 

  30. Groves C J, Howells RD, Williams S et al. Primary standardization for the ELISA of serum thyroperoxidase and thyroglobulin antibodies and their prevalence in a normal Welsh population J Clin Lab Immunol 1990 32: 147–151

    PubMed  Google Scholar 

  31. Thomas MW, Darke C . Distribution of anti-epithelial cell antibodies in normal blood donors Eur J Immunogenet 1992 19: 453

    Google Scholar 

  32. Thomas MW, Darke C . Subtypes of BFF (BFFa and BFFb) – frequency and linkage disequilibrium with HLA-B and DR alleles Eur J Immunogenet 1992 19: 454

    Google Scholar 

  33. Worwood M, Raha-Chowdhury R, Darke C . Distribution of alleles at D6S105 and D6S265 with possible HLA haplotype associations Tissue Antigens 1994 44: 322–325

    Article  CAS  Google Scholar 

  34. Thomas M, Street J, Fussell H et al. Distribution of the HLA-A9 antigen family (A23, A24 and A2403) Tissue Antigens 1996 48: 586–588

    Article  CAS  Google Scholar 

  35. Worwood M, Raha-Chowdhury R, Robson KJH et al. The HLA A1-B8 haplotype extends 6Mb beyond HLA-A: associations between HLA-A, B, F and 15 microsatellite markers Tissue Antigens 1997 50: 521–526

    Article  CAS  Google Scholar 

  36. Darke C, Winkler S, Guttridge MG et al. Molecular, serological and population studies of the alleles and products of HLA-B*41 Exp Clin Immunogenet 1999 16: 139–149

    Article  CAS  Google Scholar 

  37. Sellers J, Thompson J, Guttridge MG et al. Human platelet antigens: typing by PCR using sequence-specific primers and their distribution in blood donors resident in Wales Eur J Immunogenet 1999 26: 393–397

    Article  CAS  Google Scholar 

  38. Rees MT, Howells K, McNamara S et al. Profile of Welsh bone marrow donor registry volunteers who have donated bone marrow Eur J Immunogenet 1998 25: 67

    Google Scholar 

  39. Bishara A, Brautbar C, Cohen I et al. Positivity in a modified mixed leukocyte reaction test correlates with molecular HLA-C disparity in prediction of unrelated bone marrow transplantation outcome Hum Immunol 1999 60: 833–839

    Article  CAS  Google Scholar 

  40. Nagler A, Brautbar C, Slavin S et al. Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity Bone Marrow Transplant 1996 18: 891–897

    CAS  PubMed  Google Scholar 

  41. Bishara A, Amar A, Brautbar C et al. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Exp Hematol 1995 23: 1667–1675

    CAS  PubMed  Google Scholar 

  42. Tseng LH, Lin MT, Hansen JA et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation Blood 1999 94: 2911–2914

    CAS  PubMed  Google Scholar 

  43. Goulmy E, Schipper R, Pool J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation New Engl J Med 1996 334: 281–285

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all the registered panel donors for their continuing support. The Registry owes a considerable debt of gratitude to its actual marrow donors who have selflessly given of their compassion and time in helping to save others. We thank the dedicated staff of the Regional Tissue Typing Laboratory who have worked so ardently to ensure the success of the WBMDR during its first decade. Finally, we are greatly appreciative of the British Bone Marrow Donor Appeal for their continued financial support of the WBMDR's work.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Darke, C. An overview of the Welsh Bone Marrow Donor Registry: 10 years of bone marrow donor provision. Bone Marrow Transplant 25, 771–777 (2000). https://doi.org/10.1038/sj.bmt.1702217

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702217

Keywords

This article is cited by

Search

Quick links